Participant flow

Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer · Source last updated 2017-11-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Patients receive palonosetron hydrochloride IV on day 1. palonosetron hydrochloride: Given IV

   id

   FG000

   title

   Arm I

2. description

   Patients receive palonosetron hydrochloride IV on days 1 and 4. palonosetron hydrochloride: Given IV

   id

   FG001

   title

   Arm II

3. description

   Patients receive placebo IV on day 1. placebo: Given IV

   id

   FG002

   title

   Arm III

4. description

   Patients receive placebo IV on days 1 and 4. placebo: Given IV

   id

   FG003

   title

   Arm IV

periods

1. milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         1

      3. group Id

         FG002

         num Subjects

         3

      4. group Id

         FG003

         num Subjects

         1

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         2

      2. group Id

         FG001

         num Subjects

         1

      3. group Id

         FG002

         num Subjects

         3

      4. group Id

         FG003

         num Subjects

         1

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         0

      2. group Id

         FG001

         num Subjects

         0

      3. group Id

         FG002

         num Subjects

         0

      4. group Id

         FG003

         num Subjects

         0

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice